BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6698335)

  • 41. [Extended resection of pancreatic and periampullar carcinoma: regional, total and partial duodenopancreatectomy (author's transl)].
    Gall FP; Hermanek P; Gebhardt C; Meier H
    Leber Magen Darm; 1981 Aug; 11(4):179-84. PubMed ID: 7300546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
    Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
    Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.
    Hoffman JP; Weese JL; Solin LJ; Agarwal P; Engstrom P; Scher R; Paul AR; Litwin S; Watts P; Eisenberg BL
    Am Surg; 1993 Nov; 59(11):772-80; discussion 780-1. PubMed ID: 7902052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M; Nagakawa T; Ueno K; Ohta T; Kitagawa H; Arakawa H; Yagi H; Tajima H; Miwa K
    Hepatogastroenterology; 1998; 45(21):827-32. PubMed ID: 9684142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
    Lygidakis NJ; Stringaris K
    Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of distal pancreatectomy for pancreatic adenocarcinoma.
    Goh BK; Tan YM; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
    Dig Surg; 2008; 25(1):32-8. PubMed ID: 18292659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periampullary and pancreatic head carcinoma: facts and factors influencing mortality, survival, and quality of postoperative life.
    Lygidakis NJ; Brummelkamp WH; Tytgat GH; Huïbtegtse KH; Lubbers MJ; van der Meer AD; Schenk KE; van Gulik TM; Roesing H
    Am J Gastroenterol; 1986 Oct; 81(10):968-74. PubMed ID: 3766499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
    Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
    Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Malignant tumors of the ampulla of Vater treated by cephalic duodenopancreatectomy. Apropos of 20 case reports].
    Sastre B; Carabalona B; Crespy B; Michotey G
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):353-7. PubMed ID: 3435032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resection of cancer of the body and tail of the pancreas.
    Burcharth F; Trillingsgaard J; Olsen SD; Moesgaard F; Federspiel B; Struckmann JR
    Hepatogastroenterology; 2003; 50(50):563-6. PubMed ID: 12749273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pancreatic cancer. Analysis of 149 cases in our 17-year experience].
    Carrabetta S; De Cian F; Mondini G; Bocchio MM; D'Ambra L; Spirito C; Lazzari I; Griffanti Bartoli F; Civalleri D
    G Chir; 1998; 19(6-7):265-70. PubMed ID: 9707831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long term survival after pancreatic resection for pancreatic adenocarcinoma.
    Ahmad NA; Lewis JD; Ginsberg GG; Haller DG; Morris JB; Williams NN; Rosato EF; Kochman ML
    Am J Gastroenterol; 2001 Sep; 96(9):2609-15. PubMed ID: 11569683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic carcinoma: < or = 2 cm versus > 2 cm in size.
    Yamaguchi K; Mizumoto K; Noshiro H; Sugitani A; Shimizu S; Chijiiwa K; Tanaka M
    Int Surg; 1999; 84(3):213-9. PubMed ID: 10533779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pancreatic cancer. An appraisal of 147 cases (author's transl)].
    Hollender LF; Meyer C; Marrie A; Pierard T; Calderoli H
    Sem Hop; 1981 May 18-25; 57(19-20):1001-3. PubMed ID: 6266018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer.
    Yildirim Y; Sanci M
    Arch Gynecol Obstet; 2005 Jun; 272(1):31-4. PubMed ID: 15480722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins.
    Strasberg SM; Linehan DC; Hawkins WG
    J Am Coll Surg; 2007 Feb; 204(2):244-9. PubMed ID: 17254928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes.
    Crippa S; Tamburrino D; Partelli S; Salvia R; Germenia S; Bassi C; Pederzoli P; Falconi M
    Surgery; 2011 Jan; 149(1):79-86. PubMed ID: 20494386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.